Registered entities
Alcresta, Inc.
Reg. No. 452729951United States
ALCRESTA THERAPEUTICS, INC
Reg. No. 472729951United States
Alcresta Therapeutics, Inc.
Reg. No. 47-2729951United States
Alcresta Therapeutics, Inc.
Reg. No. 20231526714United States
Innovation
1 patent family (1 granted) — focus: Human necessities; filing pace slowing. Cited 100 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 3.4K social following, 9 posts in the last 12 months — above the industry median.
Investor mix
6 investors on record; lead investors include Third Rock Ventures, Frazier Healthcare Partners, Bessemer Venture Partners, Athyrium Capital Management; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 2 | 33% |
Recent activity
14 May 2026
Event
Cystic Fibrosis Dietitian and Social Worker Consortium Annual Meeting